Disproportionality analysis A sequential approach was adopted to systematically address major confounders: (1) An exploratory disproportionality approach comparing GLP-1RAs with all other drugs reported in the FAERS database, using venlafaxine as the positive control and empagliflozin/orlistat as the negative control
limit saturated fats, added sugar, and salt
This article dives deep into the benefits, risks, and safety strategies of GLP-1 and peptide therapies, while also highlighting how CoverWell offers unmatched protection for both patients and practices
The so-called GLP-1 patches available in the market containing herbal ingredients, may seem like a convenient option for weight management or diabetes control, but scientific evidence supporting their effectiveness is still limited
Fiber supplements do not affect the absorption or efficacy of subcutaneously injected semaglutide, tirzepatide, or retatrutide
The role of nutraceuticals in skin anti-aging